Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

arterium ltd srl - metforminum - comprimate filmate - 1000 mg

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva gyogyszergyar zrt.(teva pharm. works private) - ungaria - metforminum - compr. film. - 1000mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva gyogyszergyar zrt.(teva pharm. works private) - ungaria - metforminum - compr. film. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

Uniunea Europeană - română - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Uniunea Europeană - română - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bluefish pharmaceuticals ab - metforminum - compr. film. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bluefish pharmaceuticals ab - metforminum - compr. film. - 850mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bluefish pharmaceuticals ab - metforminum - compr. film. - 1000mg - antidiabetice orale si parenterale, exclusiv insuline biguanide

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

remedica ltd. - cipru - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

remedica ltd. - cipru - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/850mg - analogi ai glp-1 combinatii de antidiabetice orale